Our study presented preliminary data regarding PD-L1 expression measured by [99mTc]NM01 SPECT/CT and glucose metabolism measured by [18F]FDG PET/CT in normal organs of patients with advanced NSCLC undergoing anti-PD-1 immunotherapy ± chemotherapy. Here, PDCD1 is linked to non-small cell lung carcinoma.